These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 10385769)

  • 21. [Comparative study on characteristics of congestive heart failure patients with preserved versus abnormal left ventricular systolic function and evaluation effects of therapy].
    Zhan H; Tse HF; Cao JM; Lau CP
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Apr; 18(4):210-5. PubMed ID: 16647010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A management programme for suspected heart failure in primary care in cooperation with specialists in cardiology.
    Mejhert M; Kahan T
    Eur J Gen Pract; 2015 Mar; 21(1):26-32. PubMed ID: 25342003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medical management of chronic heart failure in children.
    Ross RD
    Am J Cardiovasc Drugs; 2001; 1(1):37-44. PubMed ID: 14728050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rationale and design of the third vasodilator-heart failure trial (V-HeFT III): felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in chronic congestive heart failure. V-HeFT III investigators.
    Boden WE; Ziesche S; Carson PE; Conrad CH; Syat D; Cohn JN
    Am J Cardiol; 1996 May; 77(12):1078-82. PubMed ID: 8644661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Long-term trends in drug prescription for hospitalized patients with congestive heart failure. Influence of type of dysfunction].
    Grigorian Shamagian L; Varela Román A; Virgos Lamela A; Rigueiro Veloso P; García Acuña JM; González-Juanatey JR
    Rev Esp Cardiol; 2005 Apr; 58(4):381-8. PubMed ID: 15847735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacoeconomic considerations in assessing and selecting congestive heart failure therapies.
    Levy E; Levy P
    Pharmacoeconomics; 2002; 20(14):963-77. PubMed ID: 12403637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antithrombotic therapy is associated with better survival in patients with severe heart failure and left ventricular systolic dysfunction (EPICAL study).
    Echemann M; Alla F; Briançon S; Juillière Y; Virion JM; Mertès PM; Villemot JP; Zannad F; Aliot E; Breton Ch; KhalifE K; Neimann JL; Allam S; Admant P; Baille N; Bellanger P; D'Hôtel R; Dambrine P; Dodet JF; Graille M; Kessler M; Rebeix G; Royer ; Saulnier JP; Thisse JY; Trutt B; Vidal P; Vuillemin MCh; Delahaye ; Ducimetière P; Fagnani F; Guize L;
    Eur J Heart Fail; 2002 Oct; 4(5):647-54. PubMed ID: 12413509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study.
    Kitzman DW; Gardin JM; Gottdiener JS; Arnold A; Boineau R; Aurigemma G; Marino EK; Lyles M; Cushman M; Enright PL;
    Am J Cardiol; 2001 Feb; 87(4):413-9. PubMed ID: 11179524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Congestive heart failure with preserved systolic function in a statewide sample of community hospitals.
    Dauterman KW; Go AS; Rowell R; Gebretsadik T; Gettner S; Massie BM
    J Card Fail; 2001 Sep; 7(3):221-8. PubMed ID: 11561221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
    Aronow WS
    J Lab Clin Med; 2001 May; 137(5):316-23. PubMed ID: 11329528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of advanced heart failure.
    Van Bakel AB; Chidsey G
    Clin Cornerstone; 2000; 3(2):25-35. PubMed ID: 11205722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of atrial fibrillation and severity of symptoms of heart failure in patients with low gradient aortic stenosis and preserved left ventricular ejection fraction.
    Moretti M; Fabris E; Morosin M; Merlo M; Barbati G; Pinamonti B; Gatti G; Pappalardo A; Sinagra G
    Am J Cardiol; 2014 Dec; 114(11):1722-8. PubMed ID: 25316349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function.
    Tsutsui H; Tsuchihashi M; Takeshita A
    Am J Cardiol; 2001 Sep; 88(5):530-3. PubMed ID: 11524063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacologic treatment of chronic congestive heart failure].
    Halawa B
    Przegl Lek; 1996; 53(3):119-23. PubMed ID: 8754362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: an observational study of treatment rates and clinical outcome.
    Gotsman I; Rubonivich S; Azaz-Livshits T
    Isr Med Assoc J; 2008 Mar; 10(3):214-8. PubMed ID: 18494235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence, predictive factors, and prognostic significance of supraventricular tachyarrhythmias in congestive heart failure.
    Mathew J; Hunsberger S; Fleg J; Mc Sherry F; Williford W; Yusuf S
    Chest; 2000 Oct; 118(4):914-22. PubMed ID: 11035656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of congestive heart failure in older persons.
    Aronow WS
    J Am Geriatr Soc; 1997 Oct; 45(10):1252-7. PubMed ID: 9329490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.
    McMurray JJ; Ostergren J; Swedberg K; Granger CB; Held P; Michelson EL; Olofsson B; Yusuf S; Pfeffer MA;
    Lancet; 2003 Sep; 362(9386):767-71. PubMed ID: 13678869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and prognosis of congestive heart failure in Saudi patients admitted with acute coronary syndrome (from SPACE registry).
    Albackr HB; Alhabib KF; Ullah A; Alfaleh H; Hersi A; Alshaer F; Alnemer K; Al Saif S; Taraben A; Kashour T
    Coron Artery Dis; 2013 Nov; 24(7):596-601. PubMed ID: 23928809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.